• Farzand orzusi ushalmaganlar uchun yaxshi xabar!
  • Fertillikni sezilarli oshirish mumkin!
  • Garmonlarsiz. Tadqiqotlarda isbotlangan natija!
  • Hatto PTS bilan!!
isbotlangan natija: ayollar bepushtligiga qarshi

Batafsil
QUYIDA!

Fertillik 30 yoshdan keyin kamayadi. Biz sizga yechim taqdim qilamiz.
Garmonlarsiz. Tadqiqotlarda isbotlangan natija.

fertillikni oshiruvchi vosita - profertil female

Ayollar fertilligi

  • 30 yoshdan boshlab sezilarli kamayadi
  • kech ona bo'lish trendi kuzatilyapdi(o'rtacha 29.4 yosh)
Homila tushishiga qarshi profertil female

Homila tushish xavfi

  • 35 yoshdan keyin sezilarli oshadi
  • 45 yoshdan keyin 90% dan oshadi

Speroff, Leon/Fritz, Marc A. (2005): Clinical gynecologic endocrinology and infertility, page 1016, 7th edition, Philadelphia: Lippincott Williams & Wilkins.
Heffner LJ. Advanced maternal age-how old is too old? N Engl J Med. 2004 Nov 4;351(19):1927-9.
Eurostat: average age of first-time mothers in Europe 2019

Garmonlarsiz homiladorlik preparati. 
5 muhim ijobiy o'zgarish:

Muntazam hayz ko'rish

Muntazam tsikl homiladorlik uchun muhim sharoit hisoblanadi.

Optimallashgan tuxum hujayrasi yetilishi 

Optimal sharoit yaratadi, chunki Profertil female tuxum hujayra sifatini yaxshilaydi.

Garmonsiz homiladorlik preparati 
Best chances with five crucial improvements:

Garmonsiz homiladorlik preparati 
Best chances with five crucial improvements:

Muntazam hayz ko'rish

Muntazam tsikl homiladorlik uchun muhim sharoit hisoblanadi.

Optimallashgan tuxum hujayrasi yetilishi 

Optimal sharoit yaratadi, chunki Profertil female tuxum hujayra sifatini yaxshilaydi.

Implantatsiya uchun sharoitni yaxshilaydi

Embrion implantatsiya uchun endometriyni rivojlantirish orqali yaxshi sharoit yaratadi.

Embrion rivojlanishiga yordam beradi. 

Homiladorlikdan oldin asab naychalari nuqsoni xavfini kamaytiradi va sog'lom miya va ko'rish rivojlanishini qo'llab-quvvatlaydi.

Bo'lajak onaning salomatligini qo'llab-quvvatlaydi

Preeklampsi (homiladorlik zaharlanishi) yoki erta tug'ilish xavfini kamaytiradi.

Armanini D et al. Steroids. 2004; 69 (11-12): 763–766.; Duleba AJ et al. Hum Reprod. 2004 Jul;19(7):1519-24.; Nadjarzadeh A et al. Iran J Reprod Med. 2013 Aug; 11(8): 665–672.; El Refaeey A et al. Reprod Biomed Online. 2014 Jul;29(1):119-24.; Shelly WB et al. Fertility and Sterility 2008; Volume 90, S101.; Ben-Meir A et al. Aging Cell. 2015 Oct;14(5):887-95.; Szymanski W, Kazdepka-Zieminska A. Ginekol Pol 2003;74:1392–6.; Kazerooni T et al. Int J Gynecol Obstet. 2008;101:156–160.; McCluskey S et al. Mol Cell Biochem. 1999 Apr;194(1-2):217-25.; Cicek N et al. J Assist Reprod Genet. 2012 Apr;29(4):325-8.; Letur-Konirsch H, Delanian S. Fertil Steril. 2003; 79 (2): 439–441.; Missmer SA et al. Hum Reprod. 2010 Jun;25(6):1528-35. Epub 2010 Mar 23.; Velayutham P et al. Curr Med Chem. 2008; 15(18): 1840–1850.; Nouri K. et al., Gynecol Obstet Invest. 2017;82(1):8-14.; Hager et al.; Arch Gynecol Obstet. 2019; 300(2):455-460.; Eidenberger F. et al.; First results presented by Prof. Dr. Martin Imhof at IFFS 2019. Rayman MP et al. CMAJ. 2011 Mar 22;183(5):549-55.; Amarin ZO, Obeidat AZ. Paediatr Perinat Epidemiol. 2010 Jul 1;24(4):349-51.; Kar S et al. Eur J Obstet Gynecol Reprod Biol. 2016 Mar;198:40-6.; Czeizel AE et al. Nutrients. 2013 Nov 21;5(11):4760-75.; Bukowski R et al. PLoS Med. 2009 May 5;6(5):e1000061.; Tara F et al. Taiwan J Obstet Gynecol. 2010 Jun;49(2):181-7.; Vollet K. et al.; J Dev Orig Health Dis.; 2017; 8(4):465-473.; Hammiche F. et al.; Fertil Steril.; 2011; 95(5):1820-3.

Klinik tadqiqotlar Profertil female samaradorligini isbotlaydi:

Urug'lanish darajasi

Foliy kislotasi
guruhidan
24% ko'proq

p = 0,010

Embrion sifati

Foliy kislotasi
nazorat guruhidan
24% yaxshiroq

p = 0,045

Homiladorlik darajasi

Foliy kislotasi
nazorat guruhidan
14% yaxshiroq

p = 0,141

Nouri K. et al., Gynecol Obstet Invest. 2017; 82 (1): 8-14.

Klinik tadqiqotlar Profertil female samaradorligini isbotlaydi:

Urug'lanish darajasi

Foliy kislotasi
nazorat guruhidan
24% yaxshiroq

p = 0,010

Embrion sifati

Foliy kislotasi
nazorat guruhidan
24 % yaxshiroq

p = 0,045

Homiladorlik darajasi

Foliy kislota
nazorat guruhidan
14% yaxshiroq

p = 0,141

Nouri K. et al., Gynecol Obstet Invest. 2017; 82 (1): 8-14.

Expertlar va patsientlar Profertil femlae haqida nima deydilar?

Fertillik ekspertlari PROFERTIL® female haqida

PROFERTIL® female qanday qilib homilador bo'lishga yordam berdi

faqatgina 1 yumshoq kapsula va 1 tabletka kuniga 1x mahal farzand ko'rish shansini oshiradi. Farzand ko'rish hohishi paydo bo'lgandan, homilador bo'lguncha.

Tavsiya etilgan qabul

Kuniga 1 ta yumshoq kapsula va 1 tabletkadan ovqat paytida yoki keyin bir oz suyuqlik bilan qabul qiling. Ideal holda, tabletka doimo yumshoq kapsula bilan birga ichilishi kerak. Qabul qilish bilan bog'liq qo'shimcha savollar uchun, shifokoringizga murojaat qiling. Mahsulotni faqat shifokor nazorati ostida olish kerak.

Qadoqlash hajmlari:
28 kunlik doza (oylik qadoq) va 84 kunlik doza (3-oylik qadoq)

Muvaffaqqiyatni oshirish uchun
PROFERTIL® male bilan birgalikda qabul qiling.

Fertillikni yaxshilash o'z qo'lingizda